Weitere Kapitel dieses Buchs durch Wischen aufrufen
Neurodegeneration is an alarming problem all over the globe. The significant role of SNCA receptor has been well established in several neurodegenerative disorders including various types of progressive dementia—most commonly in Parkinson’s disorder (PD) and Lewy body dementia. Phytocompounds selected from ayurvedic medicinal plants are thoroughly screened against the SNCA receptor (in silico). The gene receptor responsible for Parkinson’s disorder (PD), SNCA, was taken for this work. Mutated mammalian SNCA implicated as one of the factors responsible for PD was taken from NCBI; templates as retrieved from BLAST were downloaded from PDB. The 3D structure of SNCA was modeled; the 3D structures of phytocompounds (unknown ligands) were taken from various online databases; phytocompounds were virtually screened against the SNCA receptor, and the best ligand was selected.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Alexander, G.E., (2004), “Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder”, Dialogues Clin Neurosci., 6(3):259–280.
Thomas, B. and Beal, M.F., (2007) “Parkinson’s disease, Human Molecular Genetics”, 2007, 16(2): R183–R194.
Saha, A., (2013), “Psychiatric morbidity in Parkinson’s Disease: a case report”, American Journal of Life Sciences, 1(2):27–30.
Djamshidian, A. and Lees, A., (2012), “Impulsive Compulsive Behaviours In Patients With Parkinson’s Disease Treated With Dopamine Agonists”, Focus on Parkinson’s Disease, 23(1):16–21.
Stacy, M., (2009), “Impulse control disorders in Parkinson’s disease”, F1000 Med Rep. 1: 29.
Stacy, M., Galpern, W., Samuel, M., Lang, A., (2008), “Impulse control disorders in Parkinson’s disease abstract supplement”, Movement Disorders, 23(9):1332–1351.
Klein, C. and Westenberger, A., (2012), “Genetics of Parkinson’s Disease”, Cold Spring Harb Perspect Med., 2(1):1–15.
Dauer, W. and Przedborski, S., (2003), “Parkinson’s Disease: Mechanisms and Models”, Neuron, 2003, 39:889–909.
Rachakonda, V., Pan, T.H. and Le, W.D., (2004), “Biomarkers of neurodegenerative disorders: How good are they?”, Cell Research, 14:347–358.
George JM (2002). “The synucleins”. Genome Biol. 3 (1): REVIEWS3002.
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. (1997). “Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease”. Science. 276 (5321): 2045–7.
Goedert M (July 2001). “Alpha-synuclein and neurodegenerative diseases”. Nat. Rev. Neurosci. 2 (7): 492–501.
Shah, M., Doctoral Thesis, 2013, The cytoskeletal linker protein, Ezrin, inhibits α-synuclein fibrillization and toxicity by a novel mechanism, Freien Universität Berlin.
Sali, A. and Blundell, T.L., (1993), “Comparative protein modelling by satisfaction of spatial restraints” J. Mol. Biol., 234:779–815.
Laskoswki, R.A., MacArthur, M.W., Moss, D.S. & Thorton, J.M., (1993), “Procheck: a program to check the stereochemical quality of protein structures”, J. Appl. Cryst. 26:283–291.
Schrödinger Suite (2010) Protein Preparation Guide, SiteMap 2.4; Glide version 5.6, LigPrep 2.4, QikProp 3.3, Schrödinger, LLC, New York, NY.
Taha MO, Dahabiyeh LA, Bustanji Y, Zalloum H, Saleh S, (2008)Combining Ligand-Based Pharmacophore Modeling, Quantitative Structure-Activity Relationship Analysis and in Silico Screening for the Discovery of New Potent Hormone Sensitive Lipase Inhibitors. J Med Chem 51:6478–6494.
Singh KhD, Kirubakaran P, Nagarajan S, Sakkiah S, Muthusamy K, Velmurgan D, Jeyakanthan J (2012) Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease. J Mol Model 18: 39–51.
Duhovny D, Nussinov R, Wolfson HJ, (2002), “Efficient Unbound Docking of Rigid Molecules”, In Gusfield et al., Ed. Proceedings of the 2’nd Workshop on Algorithms in Bioinformatics (WABI) Rome, Italy, Lecture Notes in Computer Science 2452, pp. 185–200, Springer Verlag.
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ, (2005), “PatchDock and SymmDock: servers for rigid and symmetric docking”, Nucl. Acids. Res. 33: W363–367.
Yu L, Cui J, Padakanti PK, Engel L, Bagchi DP, Kotzbauer PT, and Tua Z, (2012), “Synthesis and in vitro evaluation of α-synuclein ligands”, Bioorg Med Chem., 20(15): 4625–4634.
Jayaraj RL, Ranjani V, Manigandan K And Elangovan N, (2013), “Insilico Docking Studies To Identify Potent Inhibitors Of Alpha-Synuclein Aggregation In Parkinson Disease”, Asian Journal of Pharmaceutical and Clinical Research, 6(4): 127–131.
Preenon Bagchi, Waheeta Hopper 2011 “Virtual Screening of compounds from Valeriana jatamansi with α-Synuclein” IPCBEE, 5:11–14.
Preenon Bagchi, Somashekhar. R and Ajit Kar, 2015, “Scope of some Indian medicinal plants in the management of a few neuro-degenerative disorders in-silico: a review”, International Journal of Public Mental Health & Neurosciences, 2(1):41–57.
Preenon Bagchi, Anuradha M, Ajit Kar, 2017, “Ayur-Informatics: Establishing an Ayurvedic Medication for Parkinson’s Disorder” Int’l Journal of Advances in Chemical Engg., & Biological Sciences, 4(1): 21–25.
Bagchi P, Venkatramana DK, Mahesh. M, Somashekhar. R and Kar A, 2014, “Identification of Novel Drug Leads for Receptors Implicated in Migraine from Traditional Ayurvedic Herbs Using in silico and in vitro Methods”, Journal of Neurological Disorders, 2(6):2–6 ISSN: 2329-6895.
- Pharmacophore Modeling and Docking Studies of SNCA Receptor with Some Active Phytocompounds from Selected Ayurvedic Medicinal Plants Known for their CNS Activity
- Springer Singapore
Neuer Inhalt/© ITandMEDIA